Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease

Alzheimer’s disease

Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569 · see citing works

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · see citing works

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · see citing works

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

Physiological actions of taurine

Huxtable, R. J. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.101 · Cited by 2,605 · see citing works

The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962 · see citing works

Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · see citing works

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849 · see citing works

Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · see citing works

Regulation of NMDA receptor trafficking by amyloid-β

Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · see citing works

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers

Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560 · see citing works

Long-term potentiation depends on release of d-serine from astrocytes

Henneberger, C., Papouin, T., Oliet, S. H. R., & Rusakov, D. A. (2010) · Nature · doi:10.1038/nature08673 · Cited by 1,389 · see citing works

Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · see citing works

D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor.

Mothet, J., Parent, A., Wolosker, H., Brady, R., Linden, D. J., Ferris, C., Rogawski, M., & Snyder, S. (2000) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.97.9.4926 · Cited by 1,164 · see citing works

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · see citing works

Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils

Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., & Smith, S. O. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1799 · Cited by 1,111 · see citing works

Epidemiology of Alzheimer DiseasePreprint

Mayeux, R. P., & Stern, Y. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006239 · Cited by 1,070 · see citing works

Receptor trafficking and synaptic plasticity

Collingridge, G. L., Isaac, J. T. R., & Wang, Y. T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1556 · Cited by 1,046 · see citing works

Classification and basic pathology of Alzheimer disease

Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031 · see citing works

Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers

Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954 · see citing works

Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond

Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909 · see citing works

Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine

De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882 · see citing works

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers

Bomfim, T. R., Forny‐Germano, L., Sathler, L. B., Brito‐Moreira, J., Houzel, J., Decker, H., Silverman, M. A., Kazi, H., Melo, H. M., McClean, P. L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57256 · Cited by 830 · see citing works

Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists

Papouin, T., Ladépêche, L., Ruel, J., Sacchi, S., Labasque, M., Hanini, M., Groc, L., Pollegioni, L., Mothet, J., & Oliet, S. H. R. (2012) · Cell · doi:10.1016/j.cell.2012.06.029 · Cited by 752 · see citing works

Calcium and neurodegeneration

Mattson, M. P. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00275.x · Cited by 751 · see citing works

Molecular pathways to neurodegeneration

Bossy-Wetzel, E., Schwarzenbacher, R., & Lipton, S. A. (2004) · Nature Medicine · doi:10.1038/nm1067 · Cited by 740 · see citing works

Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors

Li, S., Jin, M., Koeglsperger, T., Shepardson, N. E., Shankar, G. M., & Selkoe, D. J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0203-11.2011 · Cited by 664 · see citing works

Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers

De Felice, F. G., Vieira, M. N. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., Viola, K. L., Zhao, W.-Q., Ferreira, S. T., & Klein, W. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809158106 · Cited by 657 · cited 3× · see citing works

Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons

Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A. O., Wısnıewskı, T., Gunther, E. C., & Strittmatter, S. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3178 · Cited by 654 · see citing works

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model

Sanchez, P. E., Zhu, L., Verret, L., Vossel, K. A., Orr, A. G., Cirrito, J. R., Devidze, N., Ho, K., Yu, G.-Q., Palop, J. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121081109 · Cited by 638 · see citing works

Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer DiseasePreprint

Masters, C. L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006262 · Cited by 543 · see citing works

Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus

Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527 · see citing works

Excitotoxic and Excitoprotective Mechanisms: Abundant Targets for the Prevention and Treatment of Neurodegenerative Disorders

Mattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:2:65 · Cited by 475 · see citing works

Drug interactions at GABAA receptors

Korpi, E. R., Gründer, G., & Lüddens, H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00013-8 · Cited by 474 · see citing works

Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5

Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.029 · Cited by 468 · see citing works

The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease

Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442 · cited 5× · see citing works

Reversing EphB2 depletion rescues cognitive functions in Alzheimer model

Cissé, M., Halabisky, B., Harris, J., Devidze, N., Dubal, D. B., Sun, B., Orr, A., Lotz, G., Kim, D. H., Hamto, P., et al. (2011) · Nature · doi:10.1038/nature09635 · Cited by 433 · see citing works

Glycine binding primes NMDA receptor internalization

Nong, Y., Huang, Y., Ju, W. H., Kalia, L. V., Ahmadian, G., Wang, Y. T., & Salter, M. W. (2003) · Nature · doi:10.1038/nature01497 · Cited by 427 · see citing works

Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein

Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., & Strittmatter, S. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0395-10.2010 · Cited by 418 · see citing works

Presenilin: Running with Scissors in the Membrane

Selkoe, D. J., & Wolfe, M. S. (2007) · Cell · doi:10.1016/j.cell.2007.10.012 · Cited by 376 · see citing works

Soluble Aβ oligomer production and toxicity

Larson, M. E., & Lesné, S. E. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07478.x · Cited by 356 · see citing works

Glutamate transporters: animal models to neurologic disease

Maragakis, N. J., & Rothstein, J. D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.007 · Cited by 352 · see citing works

Functional Comparison of d ‐Serine and Glycine in Rodents: The Effect on Cloned NMDA Receptors and the Extracellular Concentration

Matsui, T., Sekiguchi, M., Hashimoto, A., Tomita, U., Nishikawa, T., & Wada, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010454.x · Cited by 334 · see citing works

Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease

Jacob, C. P., Koutsilieri, E., Bartl, J., Neuen-Jacob, E., Arzberger, T., Zander, N., Ravid, R., Roggendorf, W., Riederer, P., & Grünblatt, E. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11113 · Cited by 317 · see citing works

Neuron-derived D-Serine Release Provides a Novel Means to Activate N-Methyl-D-aspartate Receptors

Kartvelishvily, E., Shleper, M., Balan, L., Dumin, E., & Wolosker, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512927200 · Cited by 277 · see citing works

Soluble β-Amyloid1-40Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses

Roselli, F., Tirard, M., Lu, J., Hutzler, P., Lamberti, P., Livrea, P., Morabito, M. A., & Almeida, O. F. X. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3034-05.2005 · Cited by 276 · see citing works

Prion protein attenuates excitotoxicity by inhibiting NMDA receptors

Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., Chen, L., Villemaire, M., Ali, Z., Jirik, F. R., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711002 · Cited by 275 · see citing works

β‐Amyloid neurotoxicity is mediated by a glutamate‐triggered excitotoxic cascade in rat nucleus basalis

Harkany, T., Ábrahám, I. M., Timmerman, W., Laskay, G., Tóth, B., Sasvári, M., Kónya, C., Sebens, J. B., Korf, J., Nyakas, C. J., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00164.x · Cited by 275 · see citing works

d-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors

Stevens, E. R., Esguerra, M., Kim, P. M., Newman, E. A., Snyder, S., Zahs, K., & Miller, R. F. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1237052100 · Cited by 261 · see citing works

Memantine in Moderate to Severe Alzheimer’s Disease: a Meta-Analysis of Randomised Clinical Trials

Winblad, B. G., Jones, R. W., Wirth, Y., Stöffler, A., & Möbius, H. J. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000102568 · Cited by 253 · see citing works

Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N -methyl- d -aspartate receptors

You, H., Tsutsui, S., Hameed, S., Kannanayakal, T. J., Chen, L., Xia, P., Engbers, J. D. T., Lipton, S. A., Stys, P. K., & Zamponi, G. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110789109 · Cited by 243 · see citing works

Taurine prevents the neurotoxicity of β‐amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders

Louzada, P., Lima, A. C. P., Mendonça-Silva, D., Noël, F., de Mello, F. G., & Ferreira, S. (2004) · The FASEB Journal · doi:10.1096/fj.03-0739com · Cited by 239 · see citing works

Alzheimer's Disease Brain-Derived Amyloid-β-Mediated Inhibition of LTP<i>In Vivo</i>Is Prevented by Immunotargeting Cellular Prion Protein

Barry, A. E., Klyubin, I., Mc Donald, J. M., Mably, A. J., Farrell, M. A., Scott, M., Walsh, D. M., & Rowan, M. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6500-10.2011 · Cited by 237 · see citing works

Amyloid β Peptide (25–35) Inhibits Na+‐Dependent Glutamate Uptake in Rat Hippocampal Astrocyte Cultures

Harris‐White, M. E., Wang, Y., Pedigo, N. W., Hensley, K., Butterfield, D. A., & Carney, J. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010277.x · Cited by 230 · see citing works

Neuronal d-Serine and Glycine Release Via the Asc-1 Transporter Regulates NMDA Receptor-Dependent Synaptic Activity

Rosenberg, D., Artoul, S., Segal, A. C., Kolodney, G., Radzishevsky, I. S., Dikopoltsev, E., Foltyn, V. N., Inoue, R., Mori, H., Billard, J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3836-12.2013 · Cited by 228 · see citing works

Amyloid β peptide oligomers directly activate NMDA receptors

Texidó, L., Martı́n-Satué, M., Alberdi, E. M., Solsona, C., & Matute, C. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.02.001 · Cited by 223 · see citing works

Aβ-Mediated NMDA Receptor Endocytosis in Alzheimer's Disease Involves Ubiquitination of the Tyrosine Phosphatase STEP 61

Kurup, P. K., Zhang, Y., Xu, J., Venkitaramani, D. V., Haroutunian, V. H., Greengard, P., Nairn, A. C., & Lombroso, P. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0157-10.2010 · Cited by 222 · see citing works

Hippocampal Network Hyperactivity After Selective Reduction of Tonic Inhibition in GABAA Receptor α5 Subunit–Deficient Mice

Glykys, J. C., & Módy, I. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01122.2005 · Cited by 216 · see citing works

D-Serine Is the Dominant Endogenous Coagonist for NMDA Receptor Neurotoxicity in Organotypic Hippocampal Slices

Shleper, M., Kartvelishvily, E., & Wolosker, H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3190-05.2005 · Cited by 216 · see citing works

Amyloid- Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3 in Primary Cultured Hippocampal Neurons

Decker, H., Lo, K. Y., Unger, S. M., Ferreira, S. T., & Silverman, M. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1074-10.2010 · Cited by 216 · see citing works

Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease

Geddes, J. W., Chang-Chui, H., Cooper, S. M., Lott, I. T., & Cotman, C. W. (1986) · Brain Research · doi:10.1016/0006-8993(86)90611-6 · Cited by 211 · see citing works

Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death.

Camacho, A., & Massieu, L. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.05.014 · Cited by 206 · see citing works

D-Amino Acids as Putative Neurotransmitters: Focus on D-Serine

Snyder, S., & Kim, P. M. (2000) · Neurochemical Research · doi:10.1023/a:1007586314648 · Cited by 201 · see citing works

NMDA Receptor Activation Inhibits α-Secretase and Promotes Neuronal Amyloid-β Production

Lesné, S., Ali, C., Gabriel, C., Croci, N., MacKenzie, E. T., Glabe, C. G., Plotkine, M., Marchand‐Leroux, C., Vivien, D., & Buisson, A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0849-05.2005 · Cited by 198 · see citing works

Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts

Gralle, M., & Ferreira, S. T. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.02.001 · Cited by 191 · see citing works

GABAergic Function in Alzheimer's Disease: Evidence for Dysfunction and Potential as a Therapeutic Target for the Treatment of Behavioural and Psychological Symptoms of Dementia

Lanctôt, K. L., Herrmann, N., Mazzotta, P., Khan, L. R., & Ingber, N. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900705 · Cited by 191 · see citing works

Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide.

Wu, S., Bodles, A. M., Porter, M. M., Griffin, W. S. T., Basile, A. S., & Barger, S. W. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-2 · Cited by 189 · see citing works

Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption

Zhao, W.-Q., Santini, F., Breese, R., Ross, D., Zhang, X. D., Stone, D. J., Ferrer, M., Townsend, M., Wolfe, A. L., Seager, M. A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057182 · Cited by 188 · see citing works

Memantine Rescues Transient Cognitive Impairment Caused by High-Molecular-Weight A Oligomers But Not the Persistent Impairment Induced by Low-Molecular-Weight Oligomers

Figueiredo, C. P., Clarke, J. R., Ledo, J. H., Ribeiro, F. C., Costa, C., Melo, H. M., Mota-Sales, A. P., Saraiva, L. M., Klein, W. L., Sebollela, A. S., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0482-13.2013 · Cited by 181 · see citing works

β-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure

Parodí, J., Sepúlveda, F. J., Roa, J., Opazo, C., Inestrosa, N. C., & Aguayo, L. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030023 · Cited by 179 · see citing works

Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer’s disease

Rissman, R. A., & Mobley, W. C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07237.x · Cited by 172 · see citing works

Role of Kynurenines in the Central and Peripherial Nervous Systems

Nemeth, H., Toldi, J., & Vecsei, L. (2005) · Current Neurovascular Research · doi:10.2174/1567202054368326 · Cited by 169 · see citing works

N ‐Methyl‐ d ‐aspartate receptors are required for synaptic targeting of Alzheimer’s toxic amyloid‐β peptide oligomers

Decker, H., Jürgensen, S., Adrover, M. F., Brito‐Moreira, J., Bomfim, T. R., Klein, W. L., Epstein, A. L., Felice, F. G. D., Jerusalinsky, D. A., & Ferreira, S. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07058.x · Cited by 164 · see citing works

Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices

Rammes, G., Hasenjäger, A., Sroka-Saidi, K., Deussing, J. M., & Parsons, C. G. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.051 · Cited by 163 · see citing works

Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease

Wilcox, K. C., Lacor, P. N., Pitt, J. E., & Klein, W. L. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9691-4 · Cited by 156 · see citing works

Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice

Ledo, J. H., Azevedo, E. P., Clarke, J. R., Ribeiro, F. C., Figueiredo, C. P., Foguel, D., Felice, F. G. D., & Ferreira, S. T. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.168 · Cited by 156 · see citing works

Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ

Zhao, W.-Q., Lacor, P. N., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011015 · Cited by 154 · see citing works

Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative

Schneider, L. S. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.343 · Cited by 152 · see citing works

Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule

Blanchard, B. J., Chen, A., Rozeboom, L. M., Stafford, K. A., Weigele, P., & Ingram, V. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405941101 · Cited by 146 · see citing works

Human serine racemase: moleular cloning, genomic organization and functional analysis

Miranda, J. D., Santoro, A., Engelender, S., & Wolosker, H. (2000) · Gene · doi:10.1016/s0378-1119(00)00356-5 · Cited by 142 · see citing works

Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating Hyperactivity

Ballard, T. M., Pauly-Evers, M., Higgins, G. A., Ouagazzal, A., Mutel, V., Borroni, E., Kemp, J. A., Bluethmann, H., & Kew, J. N. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06713.2002 · Cited by 139 · see citing works

Amyloid β-Peptide Oligomers Stimulate RyR-Mediated Ca 2+ Release Inducing Mitochondrial Fragmentation in Hippocampal Neurons and Prevent RyR-Mediated Dendritic Spine Remodeling Produced by BDNF

Paula-Lima, A. C., Adasme, T., SanMartín, C. D., Sebollela, A. S., Hetz, C. A., Carrasco, M. A., Ferreira, S. T., & Hidalgo, C. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3287 · Cited by 136 · see citing works

Aberrant Expression of the Glutamate Transporter Excitatory Amino Acid Transporter 1 (EAAT1) in Alzheimer's Disease

Scott, H. L., Pow, D. V., Tannenberg, A. E. G., & Dodd, P. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-j0004.2002 · Cited by 127 · see citing works

Immunocytochemical analysis of D ‐serine distribution in the mammalian brain reveals novel anatomical compartmentalizations in glia and neurons

Williams, S. M., Díaz, C., Macnab, L. T., Sullivan, R., & Pow, D. V. (2005) · Glia · doi:10.1002/glia.20300 · Cited by 126 · see citing works

Regulation and Dysregulation of Glutamate Transporters

Sattler, R., & Rothstein, J. D. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_14 · Cited by 124 · see citing works

Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminili γ1 chain

Heraldo, F. H., Arantes, C., Santos, T. G., Machado, C. F., Roffé, M., Haji, G. N., Lee, K. S., Magalhães, A. C., Caetano, F. A., Mancini, G. L., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-161653 · Cited by 123 · see citing works

Treatment of CoQ10 Deficient Fibroblasts with Ubiquinone, CoQ Analogs, and Vitamin C: Time- and Compound-Dependent Effects

López, L. C., Quinzii, C. M., Área-Gómez, E., Naini, A., Rahman, S., Schuelke, M., Salviati, L., DiMauro, S., & Hirano, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011897 · Cited by 122 · see citing works

Human apolipoprotein A–I binds amyloid-β and prevents Aβ-induced neurotoxicity

Paula-Lima, A. C., Tricerri, M. A., Brito-Moreira, J., Bomfim, T. R., Oliveira, F. F., Magdesian, M. H., Grinberg, L. T., Panizzutti, R., & Ferreira, S. T. (2009) · The International Journal of Biochemistry &amp; Cell Biology · doi:10.1016/j.biocel.2008.12.003 · Cited by 121 · see citing works

Endogenous d-Serine Is Involved in Induction of Neuronal Death by N-Methyl-d-aspartate and Simulated Ischemia in Rat Cerebrocortical Slices

Katsuki, H., Nonaka, M., Shirakawa, H., Kume, T., & Akaike, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070912 · Cited by 115 · see citing works

Amyloid-β Acts as a Regulator of Neurotransmitter Release Disrupting the Interaction between Synaptophysin and VAMP2

Russell, C. L., Semerdjieva, S., Empson, R. M., Austen, B., Beesley, P. W., & Alifragis, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043201 · Cited by 115 · see citing works

Dehydroepiandrosterone Sulfate Is Neuroprotective in a Reversible Spinal Cord Ischemia Model

Lapchak, P. A., Chapman, D. F., Nunez, S., & Zivin, J. A. (2000) · Stroke · doi:10.1161/01.str.31.8.1953 · Cited by 113 · see citing works

Extra- and intracellular amino acids in the hippocampus during development of hepatic encephalopathy

Hamberger, A., & Nystr�m, B. (1984) · Neurochemical Research · doi:10.1007/bf00973033 · Cited by 112 · see citing works

The rise of a new GABA pharmacology

Möhler, H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.020 · Cited by 111 · see citing works

Amino acid abnormalities in epileptogenic foci

Perry, T. L., & Hansen, S. (1981) · Neurology · doi:10.1212/wnl.31.7.872 · Cited by 109 · see citing works

The Origin of Quantal Size Variation: Vesicular Glutamate Concentration Plays a Significant Role

Wu, X.-S., Xue, L., Mohan, R., Paradiso, K. G., Gillis, K. D., & Wu, L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4415-06.2007 · Cited by 107 · see citing works

Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study

Ułas, J., Weihmuller, F., Brunner, L., Joyce, J. N., Marshall, J. F., & Cotman, C. W. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-11-06317.1994 · Cited by 107 · see citing works

The inhibitory effects of β-amyloid on glutamate and glucose uptakes by cultured astrocytes

Parpura‐Gill, A., Beitz, D. C., & Uemura, E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00043-7 · Cited by 105 · see citing works

Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity

Frasca, A., Aalbers, M. W., Frigerio, F., Fiordaliso, F., Salio, M., Gobbi, M., Cagnotto, A., Gardoni, F., Battaglia, G. S., Hoogland, G., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.024 · Cited by 104 · see citing works

Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes

Ruiz, A., Matute, C., & Alberdi, E. M. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.31 · Cited by 102 · see citing works

Aβ Oligomers Induce Glutamate Release from Hippocampal Neurons

Brito‐Moreira, J., Paula-Lima, A. C., Bomfim, T. R., de Oliveira, F. F., Sepúlveda, F. J., Mello, F. G. D., Aguayo, L. G., Panizzutti, R., & Ferreira, S. T. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391917 · Cited by 95 · see citing works

Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from Mitochondria

Saraiva, L. M., Seixas da Silva, G. S., Galina, A., da-Silva, W. S., Klein, W. L., Ferreira, S. T., & De Felice, F. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015230 · Cited by 94 · see citing works

Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion

Zhang, F., Li, C., Wang, R., Han, D. K., Zhang, Q., Zhou, C., Yu, H., & Zhang, G.-Y. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.070 · Cited by 90 · see citing works

D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons

Martina, M., Krasteniakov, N. V., & Bergeron, R. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00411.x · Cited by 89 · see citing works

Effects of low-dose d-serine on recognition and working memory in mice

Bado, P., Madeira, C., Vargas-Lopes, C., Moulin, T. C., Wasilewska‐Sampaio, A. P., Maretti, L., de Oliveira, R. V., Amaral, O. B., & Panizzutti, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2330-4 · Cited by 88 · see citing works

Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-β Oligomers

Jürgensen, S., Antonio, L. L., Mussi, G. E. A., Brito-Moreira, J., Bomfim, T. R., De Felice, F. G., Garrido-Sanabria, E. R., Cavalheiro, É. A., & Ferreira, S. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177790 · Cited by 88 · see citing works

Group II Metabotropic Glutamate Receptor Stimulation Triggers Production and Release of Alzheimer's Amyloid β42from Isolated Intact Nerve Terminals

Kim, S. H., Fraser, P. E., Westaway, D. A., George‐Hyslop, P. S., Ehrlich, M. E., & Gandy, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4717-09.2010 · Cited by 88 · see citing works

Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons.

Paula-Lima, A., Felice, F. D. D., Brito‐Moreira, J., & Ferreira, S. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.015 · Cited by 87 · see citing works

Amyloid-β Decreases Cell-Surface AMPA Receptors by Increasing Intracellular Calcium and Phosphorylation of GluR2

Liu, S.-J., Gasperini, R., Foa, L., & Small, D. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091654 · Cited by 84 · see citing works

Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease

Koutsilieri, E., & Riederer, P. F. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70025-7 · Cited by 84 · see citing works

Amyloid-β42 Interacts Mainly with Insoluble Prion Protein in the Alzheimer Brain

Zou, W., Xiao, X., Yuan, J., Puoti, G., Fujioka, H., Wang, X., Richardson, S. L., Zhou, X., Zou, R. S., Li, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199356 · Cited by 80 · see citing works

Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study

Schwartz-Bloom, R. D., Miller, K. A., Evenson, D. A., Crain, B. J., & Nadler, J. V. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00144-5 · Cited by 80 · see citing works

Excitatory Amino Acid Neurotoxicity

Gillessen, T., Budd, S. L., & Lipton, S. A. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0123-7_1 · Cited by 79 · see citing works

CSF excitatory amino acids and severity of illness in Alzheimer's disease

Csernansky, J. G., Bardgett, M. E., Sheline, Y. I., Morris, J. C., & Olney, J. W. (1996) · Neurology · doi:10.1212/wnl.46.6.1715 · Cited by 72 · see citing works

Mechanisms of oxygen glucose deprivation-induced glutamate release from cerebrocortical slice cultures

Fujimoto, S., Katsuki, H., Kume, T., Kaneko, S., & Akaike, A. (2004) · Neuroscience Research · doi:10.1016/j.neures.2004.06.013 · Cited by 68 · see citing works

Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

Choi, S. H., Park, K. W., Na, D. L., Han, H. J., Kim, E., Shim, Y. S., Lee, J., & The EXPECT Study Group (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.582484 · Cited by 67 · see citing works

Pooled Analyses on Cognitive Effects of Memantine in Patients with Moderate to Severe Alzheimer's Disease

Emre, M., Mecocci, P., & Stender, K. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14207 · Cited by 60 · see citing works

Immunohistochemical evidences for localization and production of D-serine in some neurons in the rat brain.

Yasuda, E., Ma, N., & Semba, R. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01502-6 · Cited by 59 · see citing works

Altered γ‐secretase activity in mild cognitive impairment and Alzheimer's disease

Kakuda, N., Shoji, M., Arai, H., Furukawa, K., Ikeuchi, T., Akazawa, K., Takami, M., Hatsuta, H., Murayama, S., Hashimoto, Y., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200214 · Cited by 58 · see citing works

Cognitive dysfunction induced by sequential injection of amyloid-β and ibotenate into the bilateral hippocampus; protection by memantine and MK-801

Nakamura, S., Murayama, N., Noshita, T., Katsuragi, R., & Ohno, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.049 · Cited by 57 · see citing works

Non-plaque dystrophic dendrites in Alzheimer hippocampus: a new pathological structure revealed by glutamate receptor immunocytochemistry.

Aronica, E., Dickson, D., Kress, Y., Morrison, J. H., & Zukin, R. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00260-1 · Cited by 56 · see citing works

Amyloid β Protein Modulates Glutamate-Mediated Neurotransmission in the Rat Basal Forebrain: Involvement of Presynaptic Neuronal Nicotinic Acetylcholine and Metabotropic Glutamate Receptors

Chin, J. H., Ma, L., MacTavish, D., & Jhamandas, J. H. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1843-07.2007 · Cited by 56 · see citing works

p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma

Meley, D., Spiller, D. G., White, M., McDowell, H. P., Pizer, B. L., & Sée, V. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.16 · Cited by 55 · see citing works

Neuroprotection against Aβ and glutamate toxicity by melatonin: Are GABA receptors involved?

Paula-Lima, A. C., Louzada, P. R., Mello, F. G. D., & Ferreira, S. T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033152 · Cited by 53 · see citing works

Taurine release from the developing and ageing hippocampus: Stimulation by agonists of ionotropic glutamate receptors

Saransaari, P. (1997) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(97)00101-2 · Cited by 51 · see citing works

Slow integration leads to persistent action potential firing in distal axons of coupled interneurons

Sheffield, M. E. J., Best, T. K., Mensh, B. D., Kath, W. L., & Spruston, N. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-s1-o17 · Cited by 50 · see citing works

Excitatory Amino Acid Transporter EAAT‐2 in Tangle‐bearing Neurons in Alzheimer's Disease

Thal, D. R. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00457.x · Cited by 49 · see citing works

Newer antiepileptic drugs: advantages and disadvantages

Wallace, S. J. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00230-3 · Cited by 44 · see citing works

Memantine effects on behaviour in moderately severe to severe Alzheimer’s disease: a post-marketing surveillance study

The Memantine Lombardy Study Group, Clerici, F., Vanacore, N., Elia, A., Alegiani, S. S., Pomati, S., Cas, R. D., Raschetti, R., & Mariani, C. B. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0618-0 · Cited by 39 · see citing works

The Antioxidant N-Acetylcysteine Prevents the Mitochondrial Fragmentation Induced by Soluble Amyloid-F Peptide Oligomers

SanMartín, C. D., Adasme, T., Hidalgo, C., & Paula-Lima, A. C. (2012) · Neurodegenerative Diseases · doi:10.1159/000334901 · Cited by 38 · see citing works

The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease

Tannenberg, R. K., Scott, H. L., Westphalen, R. I., & Dodd, P. R. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480591 · Cited by 37 · see citing works

Changes in Nursing Burden Following Memantine for Agitation and Aggression in Long-Term Care Residents with Moderate to Severe Alzheimerʼs Disease

Herrmann, N., Cappell, J., Eryavec, G. M., & Lanctôt, K. L. (2011) · CNS Drugs · doi:10.2165/11588160-000000000-00000 · Cited by 33 · see citing works

Excitatory synaptic transmission is depressed in cultured hippocampal neurons of APP/PS1 mice

Priller, C., Mitteregger, G., Paluch, S., Vassallo, N., Staufenbiel, M., Kretzschmar, H. A., Jucker, M., & Herms, J. W. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.016 · Cited by 33 · see citing works

Sustained Effects of Once-Daily Memantine Treatment on Cognition and Functional Communication Skills in Patients with Moderate to Severe Alzheimer's Disease: Results of a 16-Week Open-Label Trial

Schulz, J. B., Rainer, M. K., Klünemann, H.-H., Kurz, A., Wolf, S., Sternberg, K., & Tennigkeit, F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101929 · Cited by 32 · see citing works

Prion protein attenuates excitotoxicity by inhibiting NMDA receptors

Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., Chen, L., Villemaire, M. L., Ali, Z., Jirik, F. R., et al. (2008) · The Journal of General Physiology · doi:10.1085/jgp1316oia5 · Cited by 31 · see citing works

Chronic Dietary Administration of Valproic Acid Protects Neurons of the Rat Nucleus Basalis Magnocellularis from Ibotenic Acid Neurotoxicity

Eleuteri, S., Monti, B., Brignani, S., & Contestabile, A. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9013-5 · Cited by 30 · see citing works

The role of STEP in Alzheimer's disease

Kurup, P. K., Zhang, Y., Venkitaramani, D. V., Xu, J., & Lombroso, P. J. (2010) · Channels · doi:10.4161/chan.4.5.12910 · Cited by 29 · see citing works

Dual role of glutamatergic neurotransmission on amyloid β1–42 aggregation and neurotoxicity in embryonic avian retina

Louzada, P. R., Paula-Lima, A. C., Mello, F. G. D., & Ferreira, S. T. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01585-3 · Cited by 28 · see citing works

A simple cell line based in vitro test system for N-methyl-d-aspartate (NMDA) receptor ligands

Steinmetz, R. D., Fava, E., Nicotera, P., & Steinhilber, D. (2002) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(01)00482-4 · Cited by 26 · see citing works

Regulation of spontaneous inhibitory synaptic transmission by endogenous glutamate via non-NMDA receptors in cultured rat hippocampal neurons

Vignes, M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00213-6 · Cited by 26 · see citing works

The GABAA receptor agonist THIP is neuroprotective in organotypic hippocampal slice cultures

Kristensen, B. W., Noraberg, J., & Zimmer, J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02550-2 · Cited by 25 · see citing works

d-Serine content and d-[3H]serine binding in the brain regions of the senescence-accelerated mouse

Nagata, Y., Uehara, T., Kitamura, Y., Nomura, Y., & Horiike, K. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00059-1 · Cited by 24 · see citing works

Taurine release in mouse brain stem slices under cell-damaging conditions

Saransaari, P., & Oja, S. S. (2006) · Amino Acids · doi:10.1007/s00726-006-0375-1 · Cited by 23 · see citing works

Higher susceptibility of taurine-deficient rats to seizures induced by 4-aminopyridine

Pasantes‐Morales, H., Arzate, M. E., Quesada, O., & Huxtable, R. J. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90123-7 · Cited by 22 · see citing works

In vivo co‐ordinated interactions between inhibitory systems to control glutamate‐mediated hippocampal excitability

Rodríguez, M. J., Robledo, P., Andrade, C., & Mahy, N. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03394.x · Cited by 20 · see citing works

High extracellular γ‐aminobutyric acid protects cultured neurons against damage induced by the accumulation of endogenous extracellular glutamate

Velasco, I., & Tapia, R. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10114 · Cited by 19 · see citing works

Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia

Fontaine, S. L., Mohand‐Saïd, S., Hanoteau, N., Fuchs, L., Pfizenmaier, K., & Eisel, U. L. M. (2002) · Journal of Neuroscience · Cited by 16 · see citing works

Interaction of prion protein mRNA with CBP35 and other cellular proteins Possible implications for prion replication and age-dependent changes

Müller, W. E. G., Scheffer, U., Perovic, S., Forrest, J., & Schröder, H. C. (1997) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(96)00770-4 · Cited by 8 · see citing works

Dysregulation of Ca2+ Homeostasis in Alzheimer’s Disease: Role in Acetylcholinesterase Production and AMPA Receptor Internalization

Small, D. (2012) · Neurodegenerative Diseases · doi:10.1159/000333126 · Cited by 8 · see citing works

Kainate exacerbates β-amyloid toxicity in rat hippocampus

Morimoto, K., & Oda, T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00130-7 · Cited by 8 · see citing works

Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina

Pisani, F., Costa, C., Caccamo, D., Mazzon, E., Gorgone, G., Oteri, G., Calabresi, P., & Ientile, R. (2006) · Experimental Brain Research · doi:10.1007/s00221-005-0298-1 · Cited by 6 · see citing works

Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons

Rajmohan, R., & Reddy, P. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160612 · Cited by 695 · see citing works

Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease

Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., & Battino, M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw023 · Cited by 496 · see citing works

Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease

Kaur, D., Sharma, V., & Deshmukh, R. R. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00580-x · Cited by 493 · see citing works

Glutamate and GABA Imbalance Following Traumatic Brain Injury

Guerriero, R. M., Giza, C. C., & Rotenberg, A. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0545-1 · Cited by 471 · see citing works

Synaptopathies: synaptic dysfunction in neurological disorders – A review from students to students

Lepeta, K., Lourenco, M. V., Schweitzer, B. C., Martino Adami, P. V., Banerjee, P., Catuara‐Solarz, S., de La Fuente Revenga, M., Guillem, A. M., Haidar, M., Ijomone, O. M., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13713 · Cited by 386 · see citing works

Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity: Supplementary Issue: Brain Plasticity and Repair

Beckhauser, T. F., Francis-Oliveira, J., & De Pasquale, R. (2016) · Journal of Experimental Neuroscience · doi:10.4137/jen.s39887 · Cited by 301 · see citing works

The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease

Forny‐Germano, L., Felice, F. G. D., & Vieira, M. N. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01027 · Cited by 298 · see citing works

Alzheimer's disease and the microbiome

Bhattacharjee, S., & Lukiw, W. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00153 · Cited by 248 · see citing works

Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease

Overk, C. R., & Masliah, E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.015 · Cited by 242 · see citing works

Plant alkaloids as drug leads for Alzheimer's disease

Ng, Y. P., Or, T. C. T., & Ip, N. Y. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.018 · Cited by 236 · see citing works

d-serine levels in Alzheimer’s disease: implications for novel biomarker development

Madeira, C., Lourenco, M. V., Vargas-Lopes, C., Suemoto, C. K., Brandão, C. O., Reis, T., Leite, R. E. P., Laks, J., Jacob-Filho, W., Pasqualucci, C. A., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.52 · Cited by 233 · see citing works

The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer’s Disease

Liu, Z., Li, T., Li, P., Wei, N., Zhao, Z., Liang, H., Ji, X., Chen, W., Xue, M., & Wei, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/352723 · Cited by 208 · see citing works

Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats

Singh, A. K., Kashyap, M. P., Tripathi, V., Singh, S., Garg, G., & Rizvi, S. I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0129-3 · Cited by 195 · see citing works

Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression

Madeira, C., Vargas-Lopes, C., Brandão, C. O., Reis, T., Laks, J., Panizzutti, R., & Ferreira, S. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00561 · Cited by 163 · see citing works

Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia

Lazzaro, V. D., Bella, R., Benussi, A., Bologna, M., Borroni, B., Capone, F., Chen, K.-H. S., Chen, R. E., Chistyakov, A. V., Claßen, J., et al. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.05.035 · Cited by 161 · see citing works

Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer’s disease subjects

Wood, P. L., Barnette, B. L., Kaye, J. A., Quinn, J. F., & Woltjer, R. L. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.18 · Cited by 129 · see citing works

The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review

Ambrosini, Y. M., Borcherding, D. C., Kanthasamy, A., Kim, H. J., Willette, A., Jergens, A., Allenspach, K., & Mochel, J. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00130 · Cited by 116 · see citing works

Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses

Wasser, C. R., & Herz, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.766782 · Cited by 111 · see citing works

TNFα and IL-1β but not IL-18 Suppresses Hippocampal Long-Term Potentiation Directly at the Synapse

Prieto, G. A., Tong, L., Smith, E. D., & Cotman, C. W. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2517-8 · Cited by 118 · see citing works

Sensorimotor cortex excitability and connectivity in Alzheimer's disease: A TMS-EEG Co-registration study

Ferreri, F., Vecchio, F., Vollero, L., Guerra, A., Petrichella, S., Ponzo, D., Määttä, S., Mervaala, E., Könönen, M., Ursini, F., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23158 · Cited by 111 · see citing works

Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP 3 inflammasome activation in APP / PS 1 transgenic mice

Feng, J., Wang, J., Du, Y., Liu, Y., Zhang, W., Chen, J., Liu, Y., Zheng, M., Wang, K., & He, G. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12983 · Cited by 108 · see citing works

The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease

Wang, Z.-X., Tan, L., Liu, J., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9143-0 · Cited by 110 · see citing works

The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia

Cantone, M., Pino, G. D., Capone, F., Piombo, M., Chiarello, D., Cheeran, B., Pennisi, G., & Lazzaro, V. D. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.04.010 · Cited by 102 · see citing works

Effects of Tea Catechins on Alzheimer’s Disease: Recent Updates and Perspectives

Ide, K., Matsuoka, N., Yamada, H., Furushima, D., & Kawakami, K. (2018) · Molecules · doi:10.3390/molecules23092357 · Cited by 103 · see citing works

Waste Clearance in the Brain

Kaur, J., Fahmy, L. M., Davoodi‐Bojd, E., Zhang, L., Ding, G., Hu, J., Zhang, Z., Chopp, M., & Jiang, Q. (2021) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2021.665803 · Cited by 104 · see citing works

Differentiation of Alzheimer's disease based on local and global parameters in personalized Virtual Brain models

Zimmermann, J., Perry, A., Breakspear, M. J., Schirner, M., Sachdev, P. S., Wen, W., Kochan, N. A., Mapstone, M., Ritter, P., McIntosh, A. R., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.04.017 · Cited by 97 · see citing works

Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer’s disease in wild-type, C57BL/6 mice

Torres, L., Robinson, S.-A., Kim, D.-G., Yan, A., Cleland, T. A., & Bynoe, M. S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1086-8 · Cited by 95 · see citing works

The Gastrointestinal Tract Microbiome and Potential Link to Alzheimer’s Disease

Hill, J. M., Bhattacharjee, S., Pogue, A. I., & Lukiw, W. J. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00043 · Cited by 98 · see citing works

Microtubule Dynamics in Neuronal Development, Plasticity, and Neurodegeneration

Penazzi, L., Bakota, L., & Brandt, R. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.09.004 · Cited by 94 · see citing works

Global Metabolic Shifts in Age and Alzheimer’s Disease Mouse Brains Pivot at NAD + /NADH Redox Sites

Dong, Y., & Brewer, G. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190408 · Cited by 90 · see citing works

Alzheimer’s Disease-Like Pathology Triggered by Porphyromonas gingivalis in Wild Type Rats Is Serotype Dependent

Díaz-Zúñiga, J. A., More, J., Melgar-Rodríguez, S. A., Jiménez-Unión, M., Villalobos-Orchard, F., Muñoz‐Manríquez, C., Monasterio, G., Valdés, J. L., Vernal, R., & Paula-Lima, A. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.588036 · Cited by 87 · see citing works

Traditional Ayurvedic and herbal remedies for Alzheimer’s disease: from bench to bedside

Sharma, R., Kuča, K., Nepovimová, E., Kabra, A., Rao, M. C., & Prajapati, P. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1596803 · Cited by 86 · see citing works

Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease

Silva, A. C., Lemos, C., Gonçalves, F. Q., Pliássova, A., Machado, N. J., Silva, H. B. L., Canas, P. M., Cunha, R. A., Lopes, J. P., & Agostinho, P. M. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.024 · Cited by 85 · see citing works

Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis

Mimura, Y., Nishida, H., Nakajima, S., Tsugawa, S., Morita, S., Yoshida, K., Tarumi, R., Ogyu, K., Wada, M., Kurose, S., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.003 · Cited by 85 · see citing works

Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice

Clark, J. K., Furgerson, M., Crystal, J. D., Fechheimer, M., Furukawa, R., & Wagner, J. J. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.09.003 · Cited by 87 · see citing works

The Prion Protein Ligand, Stress-Inducible Phosphoprotein 1, Regulates Amyloid-β Oligomer Toxicity

Ostapchenko, V. G., Beraldo, F. H., Mohammad, A. H., Xie, Y., Hirata, P. H. F., Magalhães, A. C., Lamour, G., Li, H., Maciejewski, A., Belrose, J. C., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3214-13.2013 · Cited by 84 · see citing works

Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease

Lombardi, V. C., Meirleir, K. L. D., Subramanian, K., Nourani, S. M., Dagda, R. K., Delaney, S. L., & Palotás, A. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.04.004 · Cited by 85 · see citing works

Interaction of amyloid‐β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice

Brito-Moreira, J., Lourenco, M. V., Oliveira, M. M., Ribeiro, F. C., Ledo, J. H., Diniz, L. P., Vital, J. F. S., Magdesian, M. H., Melo, H. M., Barros-Aragão, F., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.761189 · Cited by 84 · see citing works

Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature

Zheng, H.-F., Wang, W.-Q., Li, X., Rauw, G. A., & Baker, G. B. (2016) · Amino Acids · doi:10.1007/s00726-016-2332-y · Cited by 82 · see citing works

Amyloid, APP, and Electrical Activity of the Brain

Hefter, D., Ludewig, S., Draguhn, A., & Körte, M. (2019) · The Neuroscientist · doi:10.1177/1073858419882619 · Cited by 76 · see citing works

Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer′s disease

Tian, J., Guo, L., Sui, S., Driskill, C., Phensy, A., Wang, Q., Gauba, E., Zigman, J. M., Swerdlow, R. H., Kroener, S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav6278 · Cited by 72 · see citing works

Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer’s disease model

Kim, D. H., Lim, H., Lee, D., Choi, S. J., Oh, W., Yang, Y. S., Oh, J. S., Hwang, H. H., & Jeon, H. B. (2018) · Scientific Reports · doi:10.1038/s41598-017-18542-0 · Cited by 76 · see citing works

Signaling pathways regulating neuron–glia interaction and their implications in Alzheimer's disease

Lian, H., & Zheng, H. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13424 · Cited by 75 · see citing works

N-Acetylcysteine Prevents the Spatial Memory Deficits and the Redox-Dependent RyR2 Decrease Displayed by an Alzheimer’s Disease Rat Model

More, J., Galusso, N., Veloso, P., Montecinos, L., Finkelstein, J. P., Sánchez, G., Bull, R., Valdés, J. L., Hidalgo, C., & Paula-Lima, A. C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00399 · Cited by 71 · see citing works

Update on the Neurobiology of Vascular Cognitive Impairment: From Lab to Clinic

Vinciguerra, L., Lanza, G., Puglisi, V., Fisicaro, F., Pennisi, M., Bella, R., & Cantone, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082977 · Cited by 69 · see citing works

An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?

Sciaccaluga, M., Megaro, A., Bellomo, G., Ruffolo, G., Romoli, M., Palma, E., & Costa, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115991 · Cited by 70 · see citing works

d ‐Amino acids in biological systems

Du, S., Wey, M., & Armstrong, D. W. (2023) · Chirality · doi:10.1002/chir.23562 · Cited by 73 · see citing works

Serotype b of Aggregatibacter actinomycetemcomitans triggers pro-inflammatory responses and amyloid beta secretion in hippocampal cells: a novel link between periodontitis and Alzheimer´s disease?

Díaz-Zúñiga, J. A., Muñoz, Y., Melgar-Rodríguez, S. A., More, J., Bruna, B., Lobos, P., Monasterio, G., Vernal, R., & Paula-Lima, A. C. (2019) · Journal of Oral Microbiology · doi:10.1080/20002297.2019.1586423 · Cited by 70 · see citing works

Dihydromyricetin Ameliorates Behavioral Deficits and Reverses Neuropathology of Transgenic Mouse Models of Alzheimer’s Disease

Liang, J., Lindemeyer, A. K., Shen, Y., López-Valdés, H. E., Martínez‐Coria, H., Shao, X. M., & Olsen, R. W. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1304-4 · Cited by 66 · see citing works

Interplay of good bacteria and central nervous system: cognitive aspects and mechanistic considerations

Salami, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.613120 · Cited by 67 · see citing works

Mitochondrial plasticity and synaptic plasticity crosstalk; in health and Alzheimer's disease

Sayehmiri, F., Motamedi, F., Batool, Z., Naderi, N., Shaerzadeh, F., Zoghi, A., Rezaei, O., Khodagholi, F., & Pourbadie, H. G. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14897 · Cited by 66 · see citing works

The nuclear retention of transcription factor FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a neuroprotective role in the ageing brain

Fluteau, A., Ince, P. G., Minett, T., Matthews, F. E., Brayne, C., Garwood, C. J., Ratcliffe, L. E., Morgan, S., Heath, P. R., Shaw, P. J., et al. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.001 · Cited by 66 · see citing works

Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy

Chumakov, I. M., Nabirotchkin, S., Cholet, N., Milet, A., Boucard, A., Toulorge, D., Pereira, Y., Graudens, E., Traoré, S., Foucquier, J., et al. (2015) · Scientific Reports · doi:10.1038/srep07608 · Cited by 65 · see citing works

Astaxanthin Protects Primary Hippocampal Neurons against Noxious Effects of A β -Oligomers

Lobos, P., Bruna, B., Córdova, A., Veloso, P., Galaz, J. L., Adasme, T., Hidalgo, C., Muñoz, P., & Paula-Lima, A. C. (2016) · Neural Plasticity · doi:10.1155/2016/3456783 · Cited by 66 · see citing works

Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer’s Disease

Mahar, I., Albuquerque, M. S., Mondragon-Rodriguez, S., Cavanagh, C., Davoli, M. A., Chabot, J.-G., Williams, S., Mechawar, N., Quirion, R., & Krantic, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00327 · Cited by 63 · see citing works

Review on anti-alzheimer drug development: approaches, challenges and perspectives

Abdallah, A. E. (2024) · RSC Advances · doi:10.1039/d3ra08333k · Cited by 63 · see citing works

Inactivation of brain Cofilin-1 by age, Alzheimer's disease and γ-secretase

Barone, E., Mosser, S., & Fraering, P. C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.004 · Cited by 61 · see citing works

Neuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation

Rao, K. V. R., & Kielian, T. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12237 · Cited by 59 · see citing works

Contribution of Ca 2+ Release Channels to Hippocampal Synaptic Plasticity and Spatial Memory: Potential Redox Modulation

Paula-Lima, A. C., Adasme, T., & Hidalgo, C. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5796 · Cited by 58 · see citing works

Discovery and LC-MS Characterization of New Crocins in Gardeniae Fructus and Their Neuroprotective Potential

Ni, Y., Li, L., Zhang, W., Lu, D., Zang, C., Zhang, D., Yu, Y., & Yao, X. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b03866 · Cited by 58 · see citing works

Salivary Biomarkers for Alzheimer’s Disease: A Systematic Review with Meta-Analysis

Nijakowski, K., Owecki, W., Jankowski, J., & Surdacka, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021168 · Cited by 56 · see citing works

Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling

Liu, Y., Wang, S., Kan, J., Zhang, J., Zhou, L., Huang, Y., & Zhang, Y. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191101125530 · Cited by 55 · see citing works

Insulin and serine metabolism as sex-specific hallmarks of Alzheimer’s disease in the human hippocampus

Maffioli, E., Murtas, G., Rabattoni, V., Badone, B., Tripodi, F., Iannuzzi, F., Licastro, D., Nonnis, S., Rinaldi, A. M., Motta, Z., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111271 · Cited by 56 · see citing works

Hippocampal hyperactivity in a rat model of Alzheimer’s disease

Sosulina, L., Mittag, M., Geis, H., Hoffmann, K., Klyubin, I. V., Qi, Y., Steffen, J., Friedrichs, D., Henneberg, N., Fuhrmann, F., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15323 · Cited by 51 · see citing works

Evaluation and Treatment of Vascular Cognitive Impairment by Transcranial Magnetic Stimulation

Cantone, M., Lanza, G., Fisicaro, F., Pennisi, M., Bella, R., Lazzaro, V. D., & Pino, G. D. (2020) · Neural Plasticity · doi:10.1155/2020/8820881 · Cited by 54 · see citing works

Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer’s disease and other tauopathies

Florenzano, F., Corsetti, V., Ciasca, G., Ciotti, M. T., Pittaluga, A., Olivero, G., Feligioni, M., Iannuzzi, F., Latina, V., Sciacca, M. F. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17371 · Cited by 52 · see citing works

Environmental factors in the development and progression of late-onset Alzheimer’s disease

Wainaina, M. N., Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1425-9 · Cited by 51 · see citing works

Ionotropic glutamate receptors: Which ones, when, and where in the mammalian neocortex

Hadzic, M., Jäck, A., & Wahle, P. (2016) · The Journal of Comparative Neurology · doi:10.1002/cne.24103 · Cited by 49 · see citing works

Reduction in the neuronal surface of post and presynaptic GABABreceptors in the hippocampus in a mouse model of Alzheimer's disease

Martín‐Belmonte, A., Aguado, C., Alfaro‐Ruiz, R., Moreno‐Martínez, A. E., de la Ossa, L., Hernández, J. M., Buisson, A., Früh, S., Bettler, B., Shigemoto, R., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12802 · Cited by 49 · see citing works

Altered Neurotransmission Prior to Cognitive Decline in AβPP/PS1 Mice, a Model of Alzheimer's Disease

Hascup, K. N., & Hascup, E. R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142160 · Cited by 47 · see citing works

Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer’s Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?

Jha, S. K., Jha, N. K., Kumar, D., Sharma, R., Shrivastava, A., Ambasta, R. K., & Kumar, P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160623 · Cited by 46 · see citing works

Ryanodine receptor-mediated Ca2+ release underlies iron-induced mitochondrial fission and stimulates mitochondrial Ca2+ uptake in primary hippocampal neurons

SanMartín, C. D., Paula-Lima, A. C., García, A., Veloso, P., Härtel, S., NÃoñez, M. T., & Hidalgo, C. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00013 · Cited by 44 · see citing works

Riluzole attenuates glutamatergic tone and cognitive decline in AβPP/PS1 mice

Hascup, K. N., Findley, C. A., Britz, J., Esperant‐Hilaire, N., Broderick, S. O., Delfino, K. R., Tischkau, S. A., Bartke, A., & Hascup, E. R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15224 · Cited by 41 · see citing works

Atorvastatin Protects from Aβ1–40-Induced Cell Damage and Depressive-Like Behavior via ProBDNF Cleavage

Ludka, F. K., Cunha, M. P., Dal-Cim, T. A., Binder, L. B., Constantino, L. C., Massari, C. M., Martins, W. C., Rodrigues, A. L. S., & Tasca, C. I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0134-6 · Cited by 42 · see citing works

Dorsolateral prefrontal cortex excitability abnormalities in Alzheimer's Dementia: Findings from transcranial magnetic stimulation and electroencephalography study

Joseph, S., Knezevic, D., Zomorrodi, R., Blumberger, D. M., Daskalakis, Z. J., Mulsant, B. H., Pollock, B. G., Voineskos, A. N., Wang, W., Rajji, T. K., et al. (2021) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2021.08.008 · Cited by 36 · see citing works

Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers

Fernández-Pérez, E. J., Muñoz, B., Bascuñán, D., Peters, C., Riffo-Lepe, N., Flores-Espinoza, M. P., Morgan, P. J., Filippi, C., Bourboulou, R., Sengupta, U., et al. (2021) · Aging Cell · doi:10.1111/acel.13455 · Cited by 36 · see citing works

When, where and how? Focus on neuronal calcium dysfunctions in Alzheimer’s Disease

Agostini, M., & Fasolato, C. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.06.008 · Cited by 38 · see citing works

Beneficial effects of curtailing immune susceptibility in an Alzheimer’s disease model

Benedetto, G. D., Burgaletto, C., Carta, A. R., Saccone, S., Lempereur, L., Mulas, G., Loreto, C. D., Bernardini, R., & Cantarella, G. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1554-9 · Cited by 37 · see citing works

Biphasic Alteration of the Inhibitory Synapse Scaffold Protein Gephyrin in Early and Late Stages of an Alzheimer Disease Model

Kiss, É., Gorgas, K., Schlicksupp, A., Groß, D., Kins, S., Kirsch, J., & Kuhse, J. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.05.013 · Cited by 34 · see citing works

Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements

Shastri, D., Raj, V., & Lee, S.-K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102379 · Cited by 34 · see citing works

Genistein Inhibits Aβ25–35-Induced Synaptic Toxicity and Regulates CaMKII/CREB Pathway in SH-SY5Y Cells

Xi, Y., Zhang, D.-D., Ding, J., Yu, H., Yuan, L., Ma, W., Han, J., & Xiao, R. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0311-6 · Cited by 32 · see citing works

Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in Hippocampal Neurons

Seifert, B., Eckenstaler, R., Rönicke, R., Leschik, J., Lutz, B., Reymann, K. G., Leßmann, V., & Brigadski, T. (2016) · Neural Plasticity · doi:10.1155/2016/4145708 · Cited by 31 · see citing works

Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity

Wang, W., Voss, K., Liu, J., & Gordeev, M. F. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00524 · Cited by 31 · see citing works

Aquilariae Lignum extract attenuates glutamate-induced neuroexcitotoxicity in HT22 hippocampal cells

Lee, J., Kim, W., Jeon, Y.-J., Lee, S.-K., & Son, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.032 · Cited by 28 · see citing works

Aβ42 oligomers modulate β-secretase through an XBP-1s-dependent pathway involving HRD1

Gerakis, Y., Dunys, J., Bauer, C., & Checler, F. (2016) · Scientific Reports · doi:10.1038/srep37436 · Cited by 25 · see citing works

Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer’s and Lewy Body Diseases

Lourenco, M. V., Ribeiro, F. C., Santos, L. E., Beckman, D., Melo, H. M., Sudo, F. K., Drummond, C., Assunção, N., Vanderborght, B., Tovar-Moll, F. F., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210147 · Cited by 27 · see citing works

Astrocyte-mediated metaplasticity in the hippocampus: Help or hindrance?

Jones, O. D. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.035 · Cited by 27 · see citing works

The Transcription Factor XBP1 in Memory and Cognition: implications in Alzheimer’s Disease

Cissé, M., Duplan, E., & Checler, F. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00229 · Cited by 27 · see citing works

The Ca 2+channel inhibitor 2‐ APB reverses β ‐amyloid‐induced LTP deficit in hippocampus by blocking BAX and caspase‐3 hyperactivation

Hu, W., He, Z., Yang, L., Zhang, M., Xing, D., & Xiao, Z. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13048 · Cited by 26 · see citing works

Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia

Socha, E., Kośliński, P., Koba, M., Mądra-Gackowska, K., Kędziora–Kornatowska, K., Gackowski, M., & Daghir‐Wojtkowiak, E. (2020) · Brain Sciences · doi:10.3390/brainsci10120914 · Cited by 25 · see citing works

Glutamatergic nervous system degeneration in a C. elegans TauA152T tauopathy model involves pathways of excitotoxicity and Ca2+ dysregulation

Choudhary, B. C., Mandelkow�, E., Mandelkow, E.-M., & Pir, G. J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.005 · Cited by 26 · see citing works

Simultaneous glutamate recordings in the frontal cortex network with multisite biomorphic microelectrodes: New tools for ADHD research

Miller, E. M., Quintero, J. E., Pomerleau, F., Huettl, P. F., Gerhardt, G. A., & Glaser, P. E. A. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.01.018 · Cited by 24 · see citing works

Deciphering the intricate linkage between the gut microbiota and Alzheimer's disease: Elucidating mechanistic pathways promising therapeutic strategies

Liang, J., Wang, Y., Liu, B., Dong, X., Cai, W., Zhang, N., & Zhang, H. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14704 · Cited by 27 · see citing works

Intestinal Bacterial Flora and Alzheimer’s Disease

Bostancıklıoğlu, M. (2018) · Neurophysiology · doi:10.1007/s11062-018-9728-0 · Cited by 24 · see citing works

Neurointegrity and europhysiology: astrocyte, glutamate, and carbon monoxide interactions

Mahan, V. L. (2019) · Medical Gas Research · doi:10.4103/2045-9912.254639 · Cited by 24 · see citing works

Decoding the role of gut microbiota in Alzheimer’s pathogenesis and envisioning future therapeutic avenues

Liang, J., Liu, B., Dong, X., Wang, Y., Cai, W., Zhang, N., & Zhang, H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1242254 · Cited by 25 · see citing works

Fragile X mental retardation protein: from autism to neurodegenerative disease

Wang, H. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00043 · Cited by 23 · see citing works

Generation of the Cdk5 activator p25 is a memory mechanism that is affected in early Alzheimer’s disease

Giese, K.-P. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00036 · Cited by 22 · see citing works

Nanotechnology Building Blocks for Intervention with Alzheimer’s Disease Pathology: Implications in Disease Modifying Strategies

Nazem, A. (2014) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000101 · Cited by 20 · see citing works

Ryanodine Receptor Mediated Calcium Release Contributes to Ferroptosis Induced in Primary Hippocampal Neurons by GPX4 Inhibition

Gleitze, S., Ramírez, O. A., Vega-Vásquez, I., Yan, J., Lobos, P., Bading, H., Núñez, M. T., Paula-Lima, A. C., & Hidalgo, C. (2023) · Antioxidants · doi:10.3390/antiox12030705 · Cited by 21 · see citing works

Glutamate Receptors in Alzheimer’s Disease: Mechanisms and Therapies

Anggono, V., Tsai, L., & Götz, J. (2016) · Neural Plasticity · doi:10.1155/2016/8256196 · Cited by 22 · see citing works

Aβ Oligomers Induce Glutamate Release from Hippocampal Neurons

Brito‐Moreira, J., Paula-Lima, A. C., Bomfim, T. R., de Oliveira, F. F., Sepúlveda, F. J., Mello, F. G. D., Aguayo, L. G., Panizzutti, R., & Ferreira, S. T. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391917 · Cited by 95 · see citing works

Amyloid beta peptides and glutamatergic synaptic dysregulation

Parameshwaran, K., Dhanasekaran, M., & Suppiramaniam, V. D. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.008 · Cited by 232 · see citing works

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Tu, S., Okamoto, S., Lipton, S. A., & Xu, H. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-48 · Cited by 582 · see citing works

Glutamate receptors in preclinical research on Alzheimer's disease: Update on recent advances

Hu, N., Ondrejčák, T., & Rowan, M. J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.013 · Cited by 99 · see citing works